Jackson Creek Investment Advisors LLC Arcutis Biotherapeutics, Inc. Transaction History
Jackson Creek Investment Advisors LLC
- $332 Million
- Q4 2024
A detailed history of Jackson Creek Investment Advisors LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 151,293 shares of ARQT stock, worth $1.76 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
151,293Holding current value
$1.76 Million% of portfolio
0.63%Shares
1 transactions
Others Institutions Holding ARQT
# of Institutions
200Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC12.3MShares$143 Million0.11% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$127 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$124 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$102 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$100 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $699M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...